Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions
Clinical trial NCT03898193 · COMPLETED
Trial details
- NCT number
- NCT03898193
- Sponsor
- Pharmtechnology LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-23
- Primary completion
- 2019-04-08
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.